Cyteir Therapeutics, Inc.

CIK 1662244 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cyteir Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 29, 202415-12G0001193125-24-081446
Mar 25, 202440001373604-24-000010
Mar 21, 2024AW0001193125-24-073836
Mar 21, 2024AW0001193125-24-073844
Mar 21, 2024AW0001193125-24-073839
Mar 21, 2024S-8 POS0000950170-24-034716
Mar 21, 2024S-8 POS0000950170-24-034718
Mar 21, 2024S-8 POS0000950170-24-034713
Mar 20, 20248-K0000950170-24-034247
Mar 19, 202440001373604-24-000006
Mar 19, 202430001373604-24-000004
Mar 19, 2024SC 13G/A0001373604-24-000008
Mar 18, 2024POS AM0000950170-24-032519
Mar 18, 2024POS AM0000950170-24-032520
Mar 18, 2024POS AM0000950170-24-032521
Mar 18, 2024250001193125-24-069610
Mar 13, 2024EFFECT9999999995-24-000651
Mar 12, 2024POS AM0000950170-24-029994
Mar 12, 2024SC 13D/A0000807249-24-000031
Mar 7, 20248-K0000950170-24-028044
Mar 5, 202440001209191-24-004439
Mar 5, 202440001209191-24-004438
Feb 16, 202440001209191-24-003437
Feb 14, 202440001209191-24-003348
Feb 14, 2024SC 13G/A0001104659-24-024170